Cyclodextrin Clathrates for Cellular Hydration and Diffusion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods fail to effectively enhance biological cell activity by modifying hydration states, particularly through increasing the hydration of cellular components, which is crucial for improving cellular functions such as diffusion rates and bioavailability of molecules.

Innovation Solution

A biologically active component comprising a primary carbohydrate clathrate subcomponent, like cyclodextrins, that increases the H-bonded structure of water, forming inclusion complexes with bioactive agents to enhance cellular hydration and diffusion rates.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If conventional methods are used to deliver biological compounds, then solubility and bioavailability are limited, but the patent uses cyclodextrin clathrates to improve these properties

Engineering Contradiction:
Improvesolubility and bioavailability of pharmaceutical compoundsVSAvoidcomplexity of delivery system
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

Cyclodextrin clathrates serve as intermediary carriers that encapsulate hydrophobic biomolecules, enabling them to dissolve in aqueous environments. The cyclodextrin structure provides a hydrophobic cavity that binds the guest molecule while the exterior remains hydrophilic, acting as a mediator between incompatible phases.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention creates composite structures where cyclodextrin molecules form inclusion complexes with target biomolecules. This composite approach combines the properties of both components - the solubility-enhancing characteristics of cyclodextrins with the biological activity of the encapsulated compound.

Inventive Principle:
Principle #40Composite materials

2Speed

If water structure is not modified, then cellular diffusion rates are limited, but the patent uses cyclodextrins to increase H-bonded water structure

Engineering Contradiction:
Improvediffusion rates of molecules in cellular systemsVSAvoidcomplexity of hydration modification
Core Design Contradiction:
SpeedVSDevice complexity

Solution Approach 1:

The cyclodextrin clathrates modify the physical-chemical parameters of the aqueous environment by organizing water molecules into enhanced H-bonded networks. This changes the hydration shell properties around cellular components, facilitating faster diffusion without requiring complex external intervention.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If cellular hydration is not enhanced, then biological cell activity is limited, but the patent delivers compounds to modify mammalian physiological activity through increased hydration

Engineering Contradiction:
Improvebiological cell activity and physiological functionVSAvoidcomplexity of physiological modification system
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The cyclodextrin clathrates self-assemble in aqueous environments to form stable inclusion complexes that automatically deliver their cargo to target sites. The system utilizes the natural properties of cyclodextrins to spontaneously organize and facilitate drug delivery without requiring complex external control mechanisms.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution increases the hydration of biological cells, improving the diffusion and bioavailability of molecules, thereby supporting healthy cell functions, growth, and survival by modifying the water structure and interaction with biomolecular surfaces.

Implementation Method 1

Water molecules interact principally through hydrogen (H)-bonding and through alignment of dipole moments

Methodology Applied
Scientific EffectHydrogen bonding: Chemical Bonding

Implementation Method 2

The cyclodextrin is constructed to exhibit kosmotrope activity that increases the bonded structure of the water

Methodology Applied
Scientific EffectKosmotrope activity:

Implementation Method 3

forming inclusion complexes with bioactive agents to enhance cellular hydration and diffusion rates

Methodology Applied
Scientific EffectInclusion complex formation: Solvation

Implementation Method 4

increasing the hydration of biological cells, improving the diffusion and bioavailability of molecules

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentEP4043037A1Cellular hydration compositions containing cyclodextrins
Publication Date: 2022.08.17 EASTPOND LAB
  • EP4043037A1 patent drawingFigure 1
  • EP4043037A1 patent drawingFigure 2
  • EP4043037A1 patent drawingFigure 3

AI summary

A composition interacts with a biological cell system that includes bioactive molecules with biomolecular surfaces, cellular components and water molecules with a specific density. The composition includes a biologically active component that is constructed to increase an activity of a biological cell system by increasing the hydration of one or more components of that cell system. The biologically active component may include a primary carbohydrate clathrate subcomponent that increases the H-bonded structure of water, and a secondary solute subcomponent. The biologically active component may include an inclusion complex that is made up of a clathrate component and a complex- forming compound. The clathrate subcomponent may include amyloses or cyclodextrins. There is also a beverage and a method that improves cellular hydration in an animal, such as a human.